BD Synapsys Laboratory Software May Display Incorrect Antibiotic Susceptibility Results
BD Synapsys Informatics Solution versions 4.20–5.30 contain a software error that may incorrectly display antibiotic susceptibility results, potentially leading to inadequate or prolonged antibiotic treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device with a software error affecting critical diagnostic data and patient treatment decisions. Fits the rubric criterion of risk-of-harm products where injury has not yet been reported. No illnesses or injuries have been documented.
Plain-English summary
BD Synapsys Informatics Solution is a laboratory software for data management and workflow management in clinical diagnostic facilities. The recall affects software versions 4.20, 4.30, 5.10, 5.20, and 5.30, with 162 units distributed nationwide and internationally.
The software contains an error in its in-line breakpoint feature. When an organism is identified that belongs to an interpretive group containing a species with defined susceptibility breakpoints, the software incorrectly displays breakpoints for organisms that have no defined breakpoints in CLSI or EUCAST standards. This can result in either a false susceptible or false resistant interpretation.
A false susceptible result can cause inadequate or incomplete antibiotic treatment due to use of an ineffective antibiotic. A false resistant result may limit access to preferred antibiotic regimens with possible elongation of therapy. The software error affects the accuracy of diagnostic information used in patient care decisions.
The recalled product
- Product
- BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory software solution providing data management and workflow management functionality across locations where clinical diagnostic activities take place. Catalog Number
- Manufacturer
- Becton Dickinson & Co.
- Affected units
- 162
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- UDI-DI: 00382904441500 Software versions: 4.20
- 4.30
- 5.10
- 5.20 and 5.30
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Becton Dickinson & Co.
See all →- ModerateBD GasPak EZ Campy Pouch System Recall for Below-Specification Gas Production
FDA (Devices) · 2026-05-06
- ModerateBD GasPak EZ CO2 Pouch System gas generating sachets underperforming
FDA (Devices) · 2026-05-06
- ModerateLaboratory cuvette arrays recalled over barcodes the analyser cannot read
FDA (Devices) · 2025-11-19
- HighAutomated microbiology systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
- HighBlood culture systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
Same hazard · software error
See all →- HighQuantum Outback Powered Wheelchair Controller Recalled Due to Unexpected Braking Risk
FDA (Devices) · 2026-08-12
- HighREMISOL Advance Software Version 2.5 Recalled for Incorrect Test Result Reporting
FDA (Devices) · 2026-08-12
- HighDASH Rapid PCR Instrument Recalled Due to Software Issue Causing False Co-infection Results
FDA (Devices) · 2026-08-12
- HighQuantum Rehab R-TRAK Powered Wheelchair Controller Recalled Due to Software Issue
FDA (Devices) · 2026-08-12
- HighQuantum Rehab Q6 Edge 3 Powered Wheelchair Controller Recalled for Unexpected Braking
FDA (Devices) · 2026-08-12